Showing 221-230 of 350 grants

Title Institution Researcher Program Duration Total Award Amount
Prediction of Cancer Immunotherapy Precipitated Autoimmune Diabetes The Regents of the University of California, San Francisco Zoe Quandt Cures 01-March-2025 to 28-February-2030 $1.000.000,00
Triple therapy for T1DM with insulin, semaglutide and dapagliflozin The Research Foundation of SUNY on behalf of University at Buffalo Paresh Dandona Improving Lives 01-January-2019 to 31-December-2026 $1.808.522,70
Project Tuyinza The Sonia Nabeta Foundation Vivian Nabeta Mission 01-April-2026 to 31-March-2029 $643.550,00
Quality, Equity & Outcomes Program The Sonia Nabeta Foundation Vivian Nabeta Mission 01-September-2026 to 31-August-2028 $1.400.000,00
Dissecting HLA Mechanisms in T1D, SLE, and MS Through High-Throughput Self-Antigen Profiling The University of Chicago Aly Khan Cures 01-September-2025 to 31-August-2026 $150.000,00
Interferons and the Integrated Stress Response: Converging Pathways in β Cell Dysfunction in Type 1 Diabetes The University of Chicago Charanya Muralidharan Cures 01-March-2026 to 28-February-2029 $95.000,00
Development of β-Cell Targeted Lipid Nanoparticle Therapeutics The University of Chicago Jacob Ryan Enriquez Cures 01-March-2025 to 29-February-2028 $247.790,00
MDA5 and TRIM21 in β-cell inflammatory signaling and autoimmunity The University of Chicago Kerim Kaylan Cures 01-July-2026 to 30-June-2028 $100.000,00
A pilot study assessing the safety of using a monoclonal antibody against CD40 ligand to achieve a calcineurin inhibitor-free immunosuppression regimen in patients with type 1 diabetes mellitus (T1D) and problematic hypoglycemia undergoing islet cell transplantation The University of Chicago Piotr Witkowski Cures 01-February-2024 to 31-October-2026 $250.000,00
A pilot study assessing the safety of using a monoclonal antibody against CD40 ligand to achieve a calcineurin inhibitor-free immunosuppression regimen in patients with type 1 diabetes mellitus (T1D) and problematic hypoglycemia undergoing islet cell transplantation The University of Chicago Piotr Witkowski Cures 01-February-2025 to 31-January-2027 $1.500.000,00